2025. Artificial Intelligence–Based Evaluation of ApoA-I’s Anti-Inflammatory and Anti-Fibrotic Roles in Experimental Pulmonary Injury. Vascular and Endovascular Review. 8, 16s (Dec. 2025), 299–313.